Valvular disease pertains to a spectrum of conditions impacting the heart valves, integral structures responsible for orchestrating the seamless flow of blood within the heart. These valves—namely, the mitral, aortic, tricuspid, and pulmonary valves—work in harmony to ensure the unidirectional movement of blood. Valvular disorders can manifest in the form of stenosis, characterized by the narrowing of the valve opening, or regurgitation, involving the backflow or leakage of blood. Both scenarios compromise the heart's efficiency in pumping blood, leading to various symptoms and potential complications. Underlying causes of valvular diseases are diverse and can include congenital abnormalities, infectious agents affecting the heart valves, or degeneration associated with aging. The manifestation of symptoms varies, encompassing chest pain, fatigue, and shortness of breath, among others. Early detection and accurate diagnosis through imaging studies and echocardiograms are pivotal in initiating timely and appropriate management strategies.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States